Posted: 16-Sep-2005 << BACK
1. NAKAGAWA M, Sakamoto N, Tanabe Y, Koyama T, et al.
Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins.
Gastroenterology 2005;129:1031-41.
http://amedeo.com/p2.php?id=16143140&s=chep
ABSTRACT available
2. SIMMONDS P, Bukh J, Combet C, Deleage G, et al.
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.
Hepatology 2005;.
http://amedeo.com/p2.php?id=16149085&s=chep
ABSTRACT available
3. PEMBREYA L, Newella ML, Tovob PA.
The management of HCV infected pregnant women and their children European paediatric HCV network.
J Hepatol 2005;43:515-25.
http://amedeo.com/p2.php?id=16144064&s=chep
ABSTRACT available
4. VALENTI L, Pulixi E, Fracanzani AL, Dongiovanni P, et al.
TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.
J Hepatol 2005;.
http://amedeo.com/p2.php?id=16143422&s=chep
ABSTRACT available
5. JONSSON JR, Moschen AR, Hickman IJ, Richardson MM, et al.
Adiponectin and its receptors in patients with chronic hepatitis C.
J Hepatol 2005;.
http://amedeo.com/p2.php?id=16139921&s=chep
ABSTRACT available
6. TANG KH, Herrmann E, Cooksley H, Tatman N, et al.
Relationship between early HCV kinetics and T-cell reactivity in chronic
hepatitis C genotype 1 during peginterferon and ribavirin therapy.
J Hepatol 2005;.
http://amedeo.com/p2.php?id=16139918&s=chep
ABSTRACT available
